Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
22.98
-0.61 (-2.59%)
May 15, 2026, 4:00 PM EDT - Market closed
Alto Neuroscience Employees
Alto Neuroscience had 68 employees as of December 31, 2025. The number of employees decreased by 8 or -10.53% compared to the previous year.
Employees
68
Change (1Y)
-8
Growth (1Y)
-10.53%
Revenue / Employee
n/a
Profits / Employee
-$1,092,735
Market Cap
805.51M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 68 | -8 | -10.53% |
| Dec 31, 2024 | 76 | 9 | 13.43% |
| Sep 30, 2024 | 88 | 27 | 44.26% |
| Jun 30, 2024 | 78 | 17 | 27.87% |
| Mar 31, 2024 | 67 | - | - |
| Sep 30, 2023 | 61 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Kura Oncology | 260 |
| Xencor | 260 |
| Geron | 258 |
| Absci | 140 |
| Aura Biosciences | 113 |
| Theravance Biopharma | 90 |
| Vor Biopharma | 76 |
| CytomX Therapeutics | 69 |
ANRO News
- 20 hours ago - Alto Neuroscience CEO Amit Etkin, M.D., Ph.D. Receives Columbia University Transformational Research Award - Business Wire
- 1 day ago - Alto Neuroscience price target raised to $24 from $21 at Wedbush - TheFly
- 2 days ago - Alto Neuroscience Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 2 days ago - Alto Neuroscience reports Q1 EPS (80c) vs (56c) last year - TheFly
- 2 days ago - Alto Neuroscience Reports First Quarter 2026 Financial Results and Recent Business Highlights - Business Wire
- 4 days ago - Alto Neuroscience Announces Participation in Upcoming Investor Conferences - Business Wire
- 11 days ago - Alto Neuroscience initiated with a Buy at BofA - TheFly
- 11 days ago - Alto Neuroscience presents Phase 2a data for ALTO-207 in MDD - TheFly